| High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose … FM Kong, RK Ten Haken, MJ Schipper, MA Sullivan, M Chen, C Lopez, ... International journal of radiation oncology, biology, physics 63 (2), 324, 2005 | 669 | 2005 |
| Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma DR Wahl, MH Stenmark, Y Tao, EL Pollom, EM Caoili, TS Lawrence, ... Journal of Clinical Oncology 34 (5), 452-459, 2016 | 565 | 2016 |
| Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium F Dieterle, F Sistare, F Goodsaid, M Papaluca, JS Ozer, CP Webb, W Baer, ... Nature biotechnology 28 (5), 455-462, 2010 | 483 | 2010 |
| Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing A Eisbruch, LH Marsh, LA Dawson, CR Bradford, TN Teknos, ... International Journal of Radiation Oncology* Biology* Physics 59 (1), 28-42, 2004 | 389 | 2004 |
| Association of black race with prostate cancer–specific and other-cause mortality RT Dess, HE Hartman, BA Mahal, PD Soni, WC Jackson, MR Cooperberg, ... JAMA oncology 5 (7), 975-983, 2019 | 383 | 2019 |
| Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non–small-cell lung cancer RT Dess, Y Sun, MM Matuszak, G Sun, PD Soni, L Bazzi, VL Murthy, ... Journal of Clinical Oncology 35 (13), 1395-1402, 2017 | 351 | 2017 |
| Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis X Zheng, M Schipper, K Kidwell, J Lin, R Reddy, Y Ren, A Chang, F Lv, ... International Journal of Radiation Oncology* Biology* Physics 90 (3), 603-611, 2014 | 292 | 2014 |
| RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1 JR Prensner, S Zhao, N Erho, M Schipper, MK Iyer, SM Dhanasekaran, ... The lancet oncology 15 (13), 1469-1480, 2014 | 271 | 2014 |
| Effect of midtreatment PET/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non–small-cell lung cancer: a phase 2 clinical trial FM Kong, RK Ten Haken, M Schipper, KA Frey, J Hayman, M Gross, ... JAMA oncology 3 (10), 1358-1365, 2017 | 224 | 2017 |
| A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer E Ben-Josef, M Schipper, IR Francis, S Hadley, R Ten-Haken, T Lawrence, ... International Journal of Radiation Oncology* Biology* Physics 84 (5), 1166-1171, 2012 | 217 | 2012 |
| Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome P Panwalkar, J Clark, V Ramaswamy, D Hawes, F Yang, C Dunham, ... Acta neuropathologica 134, 705-714, 2017 | 211 | 2017 |
| Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer A Meirovitz, CA Murdoch-Kinch, M Schipper, C Pan, A Eisbruch International Journal of Radiation Oncology* Biology* Physics 66 (2), 445-453, 2006 | 206 | 2006 |
| Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes KU Hunter, M Schipper, FY Feng, T Lyden, M Haxer, CA Murdoch-Kinch, ... International Journal of Radiation Oncology* Biology* Physics 85 (4), 935-940, 2013 | 205 | 2013 |
| Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands M Little, M Schipper, FY Feng, K Vineberg, C Cornwall, ... International Journal of Radiation Oncology* Biology* Physics, 2011 | 203 | 2011 |
| Composition of the stable carotid plaque: insights from a multidetector computed tomography study of plaque volume KR Nandalur, AD Hardie, P Raghavan, MJ Schipper, E Baskurt, ... Stroke 38 (3), 935-940, 2007 | 183 | 2007 |
| Stereotactic body radiation therapy as an alternative to transarterial chemoembolization for hepatocellular carcinoma E Sapir, Y Tao, MJ Schipper, L Bazzi, PM Novelli, P Devlin, D Owen, ... International Journal of Radiation Oncology* Biology* Physics 100 (1), 122-130, 2018 | 168 | 2018 |
| Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis MH Stenmark, JB McHugh, M Schipper, HM Walline, C Komarck, FY Feng, ... International Journal of Radiation Oncology* Biology* Physics 88 (3), 580-588, 2014 | 167 | 2014 |
| Comparison of population-based observational studies with randomized trials in oncology PD Soni, HE Hartman, RT Dess, A Abugharib, SG Allen, FY Feng, ... Journal of clinical oncology 37 (14), 1209-1216, 2019 | 165 | 2019 |
| Gene amplification in esophageal adenocarcinomas and Barrett’s with high-grade dysplasia CT Miller, JR Moy, L Lin, M Schipper, D Normolle, DE Brenner, ... Clinical cancer research 9 (13), 4819-4825, 2003 | 163 | 2003 |
| Individualized adaptive stereotactic body radiotherapy for liver tumors in patients at high risk for liver damage: a phase 2 clinical trial M Feng, K Suresh, MJ Schipper, L Bazzi, E Ben-Josef, MM Matuszak, ... JAMA oncology 4 (1), 40-47, 2018 | 158 | 2018 |
Randall K. Ten HakenProfessor of Radiation Oncology, University of MichiganVerified email at umich.edu
